RESONANCE SPECIALTIES LTD.-$ (RESONANCE) Fair Value & Analysis
Basic Materials · IN · Market cap ₹1.6B
Fair value as of: Aug 20, 2026
From 24 valuation models · updated today
A solid business, but screening 15% overvalued on our models.
What matters now
- Our model range runs from ₹110.62 (bear) to ₹189.07 (bull), base ₹151.25. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 71/100 (solid quality) with high evidence: the data supports the verdict.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 20, 2026.
How to read this chart
60‑month range ₹66.47 – ₹237.37 · fair‑value band ₹110.62 – ₹189.07 · the ₹177.60 price screens above the ₹151.25 fair value. Dashed = 300-day average. As of Aug 20, 2026.
Analysis
RESONANCE SPECIALTIES LTD.-$ (RESONANCE) currently trades at ₹177.60, while our model-based Fair Value estimate is ₹151.25, implying the stock looks roughly 14.8% overvalued today. The Quality Score stands at 71/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, RESONANCE SPECIALTIES LTD.-$ generated revenue of ₹902M at a net margin of 11.5%. Revenue grew 1.1% year over year. It earns a return on equity of 15.2%. Net debt stands at ₹18.8M. Fundamentals as of Aug 20, 2026
Our scenario range runs from ₹110.62 (bear case) to ₹189.07 (bull case); at ₹177.60, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 131% above its 52-week low, currently above its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -55% fair-value upside, at -15%, RESONANCE screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: DCF Models (₹168.91) versus Asset-Based (₹42.51). Highest evidence: Growth DCF (80).
Notify me when RESONANCE reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 20, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 70 · Market factors (momentum, volatility) 84
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Resonance Specialties Limited engages in the manufacture and marketing of specialty chemicals in India and internationally.
Full company description
Resonance Specialties Limited engages in the manufacture and marketing of specialty chemicals in India and internationally. It offers pyridine, a chemical used in manufacturing agrochemicals, pharmaceuticals and bulk drugs, dyes, rubber chemicals, etc.; cyanopyridines that are applied in manufacturing of niacinamide; and picolines, including alpha, beta, and gamma picolines used in manufacturing vinyl latex rubber, vitamin B3, and anti-tuberculosis drugs. The company also provides nutritional drug products, such as zinc and chromium picolinate, chromium polynicotinate, niacin, niacinamide, and Isoniazid; alpha picolinic and dipicolinic acids; solvents, including acetonitrile and valeronitrile; lutidines for anti-ulcer drugs; and collidines for omeprazole, lansoprazole, rebaprazole, and esomeprazole. The company was formerly known as Armour Polymers Limited. Resonance Specialties Limited was incorporated in 1989 and is based in Mumbai, India.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
RESONANCE SPECIALTIES LTD.-$ reported revenue of ₹902M in FY2025 versus ₹742M in FY2021, a compound +5.0%/yr. Reported net income was ₹104M in FY2025, compounding −4.2%/yr from FY2021.
RESONANCE screens 15% overvalued. Compare with BASF SE →
Peer Group
Chemicals · 333 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Chemicals median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Aug 20, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| BASF SE BASN | 1,034 MXN | 467.04 MXN | -55% |
| PT Barito Pacific Tbk, BRPT | 1,855 IDR | 1,584 IDR | -15% |
| LG Chem, Ltd 051910 | 275,500 KRW | 587,755 KRW | +113% |
| SRF Limited 503806 | ₹2,609 | ₹749.17 | -71% |
| 542812 542812 | ₹4,709 | ₹791.05 | -83% |
| Navin Fluorine International Limited NAVINFLUOR | ₹8,357 | ₹2,146 | -74% |
| Deepak Nitrite Limited DEEPAKNI | ₹1,768 | ₹824.05 | -53% |
| 523642 523642 | ₹2,484 | ₹1,745 | -30% |
| 506285 506285 | ₹4,048 | ₹1,589 | -61% |
| Kansai Nerolac Paints Limited 500165 | ₹209.25 | ₹80.51 | -62% |
Compare RESONANCE SPECIALTIES LTD.-$ with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is RESONANCE SPECIALTIES LTD.-$ (RESONANCE) overvalued or undervalued?
What is the fair value of RESONANCE?
What is the quality score of RESONANCE?
What is the revenue of RESONANCE SPECIALTIES LTD.-$ (RESONANCE)?
What is the net profit margin of RESONANCE?
Does RESONANCE SPECIALTIES LTD.-$ pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track RESONANCE SPECIALTIES LTD.-$ and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.